Novel integrative genomic tool for interrogating lithium response in bipolar disorder
- PMID: 25646593
- PMCID: PMC4445744
- DOI: 10.1038/tp.2014.139
Novel integrative genomic tool for interrogating lithium response in bipolar disorder
Abstract
We developed a novel integrative genomic tool called GRANITE (Genetic Regulatory Analysis of Networks Investigational Tool Environment) that can effectively analyze large complex data sets to generate interactive networks. GRANITE is an open-source tool and invaluable resource for a variety of genomic fields. Although our analysis is confined to static expression data, GRANITE has the capability of evaluating time-course data and generating interactive networks that may shed light on acute versus chronic treatment, as well as evaluating dose response and providing insight into mechanisms that underlie therapeutic versus sub-therapeutic doses or toxic doses. As a proof-of-concept study, we investigated lithium (Li) response in bipolar disorder (BD). BD is a severe mood disorder marked by cycles of mania and depression. Li is one of the most commonly prescribed and decidedly effective treatments for many patients (responders), although its mode of action is not yet fully understood, nor is it effective in every patient (non-responders). In an in vitro study, we compared vehicle versus chronic Li treatment in patient-derived lymphoblastoid cells (LCLs) (derived from either responders or non-responders) using both microRNA (miRNA) and messenger RNA gene expression profiling. We present both Li responder and non-responder network visualizations created by our GRANITE analysis in BD. We identified by network visualization that the Let-7 family is consistently downregulated by Li in both groups where this miRNA family has been implicated in neurodegeneration, cell survival and synaptic development. We discuss the potential of this analysis for investigating treatment response and even providing clinicians with a tool for predicting treatment response in their patients, as well as for providing the industry with a tool for identifying network nodes as targets for novel drug discovery.
Figures



Similar articles
-
Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.Pharmacogenomics J. 2016 Oct;16(5):446-53. doi: 10.1038/tpj.2016.50. Epub 2016 Jul 12. Pharmacogenomics J. 2016. PMID: 27401222 Clinical Trial.
-
Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder.BMC Psychiatry. 2022 Oct 27;22(1):665. doi: 10.1186/s12888-022-04286-3. BMC Psychiatry. 2022. PMID: 36303132 Free PMC article.
-
Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis.Mol Psychiatry. 2024 Jan;29(1):6-19. doi: 10.1038/s41380-022-01909-9. Epub 2023 Mar 29. Mol Psychiatry. 2024. PMID: 36991131 Free PMC article.
-
Genetics of Lithium Response in Bipolar Disorder.Pharmacopsychiatry. 2018 Sep;51(5):206-211. doi: 10.1055/a-0590-4992. Epub 2018 Mar 26. Pharmacopsychiatry. 2018. PMID: 29579760 Review.
-
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.Mol Psychiatry. 2015 Jun;20(6):661-70. doi: 10.1038/mp.2015.4. Epub 2015 Feb 17. Mol Psychiatry. 2015. PMID: 25687772 Free PMC article. Review.
Cited by
-
Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:87-103. doi: 10.1016/j.pnpbp.2016.03.010. Epub 2016 Apr 9. Prog Neuropsychopharmacol Biol Psychiatry. 2017. PMID: 27072377 Free PMC article. Review.
-
Detecting suicide risk in bipolar disorder patients from lymphoblastoid cell lines genetic signatures.Transl Psychiatry. 2025 Sep 3;15(1):339. doi: 10.1038/s41398-025-03573-3. Transl Psychiatry. 2025. PMID: 40903457 Free PMC article.
-
Divergent Directionality of Immune Cell-Specific Protein Expression between Bipolar Lithium Responders and Non-Responders Revealed by Enhanced Flow Cytometry.Medicina (Kaunas). 2023 Jan 7;59(1):120. doi: 10.3390/medicina59010120. Medicina (Kaunas). 2023. PMID: 36676744 Free PMC article.
-
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder.Int J Mol Sci. 2019 Nov 30;20(23):6040. doi: 10.3390/ijms20236040. Int J Mol Sci. 2019. PMID: 31801218 Free PMC article.
-
RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers.Int J Mol Sci. 2023 Jun 13;24(12):10067. doi: 10.3390/ijms241210067. Int J Mol Sci. 2023. PMID: 37373213 Free PMC article. Review.
References
-
- Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50:143–151. - PubMed
-
- Goodwin F, Jamison K. Manic-Depressive Illness. Oxford University Press: Oxford, UK; 2007.
-
- Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, et al. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord. 2007;104:185–190. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials